In situ analyses of genome instability in breast cancer
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Transition through telomere crisis is thought to be a crucial event in the development of most breast carcinomas. Our goal in this study was to determine where this occurs in the context of histologically defined breast cancer progression. To this end, we assessed genome instability (using fluorescence in situ hybridization) and other features associated with telomere crisis in normal ductal epithelium, usual ductal hyperplasia, ductal carcinoma in situ and invasive cancer. We modeled this process in vitro by measuring these same features in human mammary epithelial cell cultures during ZNF217-mediated transition through telomere crisis and immortalization. Taken together, the data suggest that transition through telomere crisis and immortalization in breast cancer occurs during progression from usual ductal hyperplasia to ductal carcinoma in situ.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An analysis of genome instability and other features associated with telomere crisis, including anaphase and chromatin bridges, suggests that transition through telomere crisis in breast cancer occurs during progression from usual ductal hyperplasia (UDH) to ductal carcinoma in situ (DCIS)145.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [145]
In the citing paper
“Short telomeres and a sharp increase in genome instability are observed in the early stages of breast cancer before telomerase activation and genome stabilization [353].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [353]
In the citing paper
“telomeres were shown to be shorter in invasive cancers Telomeres and telomerase in cancer of the breast, prostate and pancreas, as well as in their pre-invasive counterparts (123-126).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [124]
In the citing paper
“Recent observations indicate that both telomere dysfunction73, 74 and the DDR75, 76 are activated at the earliest stages in many human carcinomas.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [73]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829 · cited 1×
“This may explain why the risk of developing invasive cancer in individuals with UDH is only modestly increase”
BackgroundTelomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Assembly of microarrays for genome-wide measurement of DNA copy number
Snijders, A. M., Nowak, N., Segraves, R., Blackwood, S., Brown, N., Conroy, J., Hamilton, G., Hindle, A. K., Huey, B., Kimura, K., et al. (2001) · Nature Genetics · doi:10.1038/ng754 · Cited by 999 · cited 1×
“We analyzed genome copy-number changes using array CGH as described previousl”
MethodSelf-citationRegulation of Telomerase by Telomeric Proteins
Smogorzewska, A., & de Lange, T. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.071403.160049 · Cited by 798 · cited 1×
“Most epithelial cells lack active telomerase, and so extended proliferation leads to telomere erosion and, eventually, loss of telomere functio”
BackgroundConnecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561 · cited 1×
“The molecular events that enable normal epithelial cells to progress to invasive, metastatic disease are increasingly well understoo”
BackgroundNormal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes
Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., & Tlsty, T. D. (2001) · Nature · doi:10.1038/35054579 · Cited by 560
Self-citationERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
Kallioniemi, O. P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., & Gray, J. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5321 · Cited by 555
Self-citationTelomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · cited 1×
“and are almost always eliminated by damage-surveillance mechanism”
Background
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
“Circumstantial support for the importance of transient telomere deficiency in facilitating malignant progression has come, in addition, from comparative analyses of premalignant and malignant lesions in the human breast (Raynaud et al., 2010; Chin et al., 2004).”
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Genetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Bissell, M. J., & Hines, W. C. (2011) · Nature Medicine · doi:10.1038/nm.2328 · Cited by 1,517
“Despite the myriad of mutations and changes in the genome, the majority of which are identical to those in the frank tumor”
BackgroundGenomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,317
“…copy number changes in the ZNF217-transfected human mammary epithelial cells that emerged after passage through telomere crisis having achieved clonal dominance in the culture (Chin et al., 2004; see Figure S2)—presumably because the aberrations they carried conferred a proliferative advantage.”
Self-citationSystemic Spread Is an Early Step in Breast Cancer
Hüsemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., Forni, G., Eils, R., Fehm, T., Riethmüller, G., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.003 · Cited by 1,188
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Telomeres in cancer: tumour suppression and genome instability
Maciejowski, J., & de Lange, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.171 · Cited by 745
Breast cancer: origins and evolution
Polyak, K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33295 · Cited by 697
Lovejoy, C. A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J. H. J., Sung, P. A., Jasin, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002772 · Cited by 629
“In cells that have been immortalized by telomerase activation, the telomere-driven genome instability is largely dampened, resulting in a rearranged but now relatively stable karyotype [43,44].”
BackgroundLi, S., Shen, D., Shao, J., Crowder, R., Liu, W., Prat, A., He, X., Liu, S., Hoog, J., Lu, C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.022 · Cited by 626
“of SVs was striking, suggesting that these genomic features may stabilize early in pathogenesis, perhaps during telomere crisis (Chin et al., 2004).”
Aurora B-Mediated Abscission Checkpoint Protects against Tetraploidization
Steigemann, P., Wurzenberger, C., Schmitz, M. H. A., Held, M., Guizetti, J., Maar, S., & Gerlich, D. W. (2009) · Cell · doi:10.1016/j.cell.2008.12.020 · Cited by 620
“, 2007), it could also reduce the risk of cancer in aging tissues, where the incidence of chromosome bridges increases due to telomere attrition (Chin et al., 2004; Maser and DePinho, 2002; Stewenius et al., 2005).”
Array comparative genomic hybridization and its applications in cancer
Pinkel, D., & Albertson, D. G. (2005) · Nature Genetics · doi:10.1038/ng1569 · Cited by 585
“Ongoing genomic instability results in heterogeneity that is not detectable by CGH and is best assessed by techniques that examine individual cell”
MethodPunctuated copy number evolution and clonal stasis in triple-negative breast cancer
Gao, R., Davis, A., McDonald, T. O., Sei, E., Shi, X., Wang, Y., Tsai, P.-C., Casasent, A., Waters, J., Zhang, H., et al. (2016) · Nature Genetics · doi:10.1038/ng.3641 · Cited by 523
Context, tissue plasticity, and cancerAre tumor stem cells also regulated by the microenvironment?
BISSELL, M., & LABARGE, M. (2005) · Cancer Cell · doi:10.1016/s1535-6108(04)00375-7 · Cited by 255
“It appears that cells can incur a great deal of damage to their genetic programming and still remain phenotypically dormant (Chin et al., 2004).”
BackgroundRegulation of In Situ to Invasive Breast Carcinoma Transition
Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Violette, S., Nikolskaya, T., Nikolsky, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.007 · Cited by 502
“Human DCIS has been shown to have numerous genetic alterations and is almost indistinguishable from the invasive tumors (Chin et al., 2004).”
BackgroundTelomere length and risk of incident cancer and cancer mortality
Willeit, P., Willeit, J., Mayr, A., Weger, S., Oberhollenzer, F., Brandstätter, A., Kronenberg, F., & Kiechl, S. (2010) · JAMA · doi:10.1001/jama.2010.897 · Cited by 484
The new cytogenetics: blurring the boundaries with molecular biology
Speicher, M. R., & Carter, N. P. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1692 · Cited by 458
“For example, this advantage of interphase FISH allowed the observation to be made that TELOMERE CRISIS occurs at an early stage in the development of breast cance”
BackgroundThe causes and consequences of polyploidy in normal development and cancer
Davoli, T., & de Lange, T. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154234 · Cited by 424
Telomere dysfunction and tumour suppression: the senescence connection
Deng, Y., Chan, S. S., & Chang, S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2393 · Cited by 411
“Recent observations indicate that both telomere dysfunctio”
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing
Casasent, A. K., Schalck, A., Gao, R., Sei, E., Long, A., Pangburn, W., Casasent, T., Meric-Bernstam, F., Edgerton, M. E., & Navin, N. E. (2018) · Cell · doi:10.1016/j.cell.2017.12.007 · Cited by 411
“Although the mechanisms of punctuated copy number evolution remain unknown, we speculate that telomere crisis (Chin et al., 2004) is a plausible model.”
Hypermutation in human cancer genomes: footprints and mechanisms
Roberts, S. A., & Gordenin, D. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3816 · Cited by 405
Mechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
“Short telomeres and a sharp increase in genome instability are observed in the early stages of breast cancer before telomerase activation and genome stabilization [353].”
BackgroundMicroenvironmental regulation of cancer development
Hu, M., & Polyak, K. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.006 · Cited by 330
Designing a broad-spectrum integrative approach for cancer prevention and treatment
Block, K. I., Gyllenhaal, C., Lowe, L., Amedei, A., Amin, A. R. M. R., Amin, A., Aquilano, K., Arbiser, J., Arreola, A., Arzumanyan, A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.007 · Cited by 300
“When acquired by somatic cells that have sustained genetic damage or instability, replicative immortality allows accumulation of sequential aberrations that confer autonomous growth, invasiveness, and therapeutic resistance [106].”
BackgroundPersistent Telomere Damage Induces Bypass of Mitosis and Tetraploidy
Davoli, T., Denchi, E. L., & de Lange, T. (2010) · Cell · doi:10.1016/j.cell.2010.01.031 · Cited by 298
“In agreement, extreme telomere shortening is observed in the early stages of tumorigenesis before telomerase is activated (Chin et al., 2004).”
Selection and adaptation during metastatic cancer progression
Klein, C. A. (2013) · Nature · doi:10.1038/nature12628 · Cited by 273
The Role of Aneuploidy in Cancer Evolution
Sansregret, L., & Swanton, C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028373 · Cited by 266
“…transient telomere crisis during early stages of breast cancer, followed by stabilization of shorter telomeres through telomerase reactivation, was shown for several cancers including prostate (Meeker et al. 2002), colon (Rudolph et al. 2001), and pancreas (Chin et al. 2004; Feldmann et al. 2007).”
BackgroundSchardt, J. A., Meyer, M., Hartmann, C. H., Schubert, F., Schmidt-Kittler, O., Fuhrmann, C., Polzer, B., Petronio, M., Eils, R., & Klein, C. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.003 · Cited by 259
“, before the cancer becomes morphologically invasive (Chin et al., 2004).”
BackgroundDavoli, T., & de Lange, T. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.044 · Cited by 242
“Furthermore, telomere crisis was inferred to occur in the ductal carcinoma in situ (DCIS) stage of breast cancer based on the presence of short telomeres and an abrupt rise in genome instability before telomerase is activated (Chin et al., 2004).”
Telomeres, chromosome instability and cancer
Bailey, S. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl303 · Cited by 243
“Therefore, although chromosomal rearrangements due to telomere loss in cancer cells are commonly thought to result from the extensive chromosome fusion that occurs during crisis (146,147), a high rate of telomere loss is often observed even in human tumors and tumor cell lines that express telomerase (73,140,144,148,1…”
BackgroundSignificant Role for p16INK4a in p53-Independent Telomere-Directed Senescence
Jacobs, J. J. L., & de Lange, T. (2004) · Current Biology · doi:10.1016/j.cub.2004.12.025 · Cited by 237
Suram, A., Kaplunov, J., Patel, P. L., Ruan, H., Cerutti, A., Boccardi, V., Fumagalli, M., Di Micco, R., Mirani, N., Gurung, R. L., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.132 · Cited by 227
“While the reasons for these differences are currently unknown, it is tempting to speculate that the decreased sensitivity to dysfunctional telomeres is a feature of cells in highly proliferative tissues such as colon and breast.”
Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field
Kuerer, H. M., Albarracin, C. T., Yang, W. T., Cardiff, R. D., Brewster, A. M., Symmans, W. F., Hylton, N. M., Middleton, L. P., Krishnamurthy, S., Perkins, G. H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.3103 · Cited by 228
Ding, Z., Wu, C.-J., Jaskelioff, M., Ivanova, E., Kost-Alimova, M., Protopopov, A., Chu, G. C., Wang, G., Lu, X., Labrot, E. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.039 · Cited by 220
“, 2002), breast (Chin et al., 2004), and pancreas (Feldmann et al.”
Hypoxia and adaptive landscapes in the evolution of carcinogenesis
Gillies, R. J., & Gatenby, R. A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9065-z · Cited by 215
“In fact the “telomere crisis” and subsequent changes in telomerase expression and activity are wellestablished and account for the limitless replicative ability that constitutes another of the hallmarks of cancer (Fig. 2) [14, 15 ].”
BackgroundCosme‐Blanco, W., Shen, M., Lazar, A. J. F., Pathak, S., Lozano, G., Multani, A. S., & Chang, S. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7400937 · Cited by 205
COMPARATIVE GENOMIC HYBRIDIZATION
Pinkel, D., & Albertson, D. G. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162140 · Cited by 203
Cell-Matrix Interactions in Mammary Gland Development and Breast Cancer
Muschler, J., & Streuli, C. H. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003202 · Cited by 204
“Extensive genomic alterations and variations in histological grade can accumulate within in situ carcinomas, but the cells remain caged as a benign lesion by the presence of the BM (Allred et al. 2008; Chin et al. 2004; Hwang et al. 2004).”
BackgroundGatbonton, T., Imbesi, M., Nelson, M., Akey, J. M., Ruderfer, D. M., Kruglyak, L., Simon, J. A., & Bedalov, A. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020035 · Cited by 206
“The role of telomere attrition in human carcinogenesis has been directly demonstrated by capturing telomere loss-induced chromosomal bridges in precancerous lesions in human colon [35] and breast [36].”
Telomere shortening in human diseases
Kong, C. M., Lee, X. W., & Wang, X. (2013) · The FEBS Journal · doi:10.1111/febs.12326 · Cited by 194
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
Calado, R. T., Regal, J. A., Hills, M., Yewdell, W. T., Dalmazzo, L. F., Zago, M. A., Lansdorp, P. M., Hogge, D., Chanock, S. J., Estey, E. H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807057106 · Cited by 184
“In human cancer cells, telomere dysfunction coincides with the progression of breast cancer from ductal hyperplasia to ductal carcinoma in situ (27).”
BackgroundTelomere-related Genome Instability in Cancer
DE LANGE, T. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.032 · Cited by 182
“The notion that tumors develop through a brief period of telomere dysfunction that generates extensive genetic diversity is borne out by data on genomic alterations during the development of breast cancer (Chin et al. 2004).”
BackgroundLin, T. T., Letsolo, B. T., Jones, R. E., Rowson, J., Pratt, G., Hewamana, S., Fegan, C., Pepper, C., & Baird, D. M. (2010) · Blood · doi:10.1182/blood-2010-02-272104 · Cited by 178
Yao, J., Weremowicz, S., Feng, B., Gentleman, R. C., Marks, J. R., Gelman, R., Brennan, C., & Polyak, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4083 · Cited by 179
“1C), correlating with prior studies describing high degree of genomic instability at this early stage of breast tumorigenesis (30).”
BackgroundTelomeres and chromosome instability
Murnane, J. P. (2006) · DNA Repair · doi:10.1016/j.dnarep.2006.05.030 · Cited by 175
Roylance, R., Endesfelder, D., Gorman, P., Burrell, R. A., Sander, J., Tomlinson, I., Hanby, A. M., Speirs, V., Richardson, A. L., Birkbak, N. J., et al. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0343 · Cited by 175
“40 3 106 (43) 23 (30) 31 (40) 34 (58) 18 (55) 0.”
Systematic genome instability screens in yeast and their potential relevance to cancer
Yuen, K. W. Y., Warren, C. D., Chen, O., Kwok, T., Hieter, P., & Spencer, F. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610642104 · Cited by 176
Stop pulling my strings — what telomeres taught us about the DNA damage response
Lazzerini-Denchi, E., & Sfeir, A. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.43 · Cited by 170
Stochastic cancer progression driven by non‐clonal chromosome aberrations
Heng, H. H. Q., Stevens, J. B., Liu, G., Bremer, S. W., Ye, K. J., Reddy, P., Wu, G. S., Wang, Y. A., Tainsky, M. A., & Ye, C. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20685 · Cited by 162
“Similarly, increased aneuploidy has been observed as a major genomic change after carcinogenic challenges (Duesberg, 2005; Li et al., 2005).”
BackgroundThe Role of Telomere Biology in Cancer
Xu, L., Li, S., & Stohr, B. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164030 · Cited by 160
Sabatier, L., Ricoul, M., Pottier, G., & Murnane, J. P. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0194 · Cited by 160
“However, it is now clear that cancer cells often continue to have problems maintaining telomeres even after the expression of telomerase (15, 16), indicating a fundamental defect affecting telomere stability in cancer cells (20).”
BackgroundGarbe, J. C., Bhattacharya, S., Merchant, B., Bassett, E., Swisshelm, K., Feiler, H. S., Wyrobek, A. J., & Stampfer, M. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0270 · Cited by 157
“This distinction may also be significant for modeling malignant progression; genomic instability and telomerase reactivation are first seen at the ductal carcinoma in situ stage and are not found in atypical hyperplasia (5, 9, 15, 16).”
Self-citationMuggerud, A. A., Rønneberg, J. A., Wärnberg, F., Botling, J., Busato, F., Jovanovic, J., Solvang, H., Bukholm, I., Børresen-Dale, A.-L., Kristensen, V. N., et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2466 · Cited by 160
“Introduction The multistep model of breast cancer progression suggests a transition from normal epithelium to invasive carcinoma via intraductal hyperplasia and in situ carcinoma [1].”
Backgroundde Castro, N. P., Osório, C. A. B. D. T., Torres, C., Bastos, E. P., Mourão-Neto, M., Soares, F. A., Brentani, H., & Carraro, D. M. (2008) · Breast Cancer Research · doi:10.1186/bcr2157 · Cited by 167
“Molecular and pathological evidence suggests that DCIS can be precursor to invasive disease (although this is not without exception) [5-11].”
BackgroundGenomic instability in breast cancer: Pathogenesis and clinical implications
Kwei, K. A., Kung, Y., Salari, K., Holcomb, I. N., & Pollack, J. R. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.001 · Cited by 154
Çolak, D., Nofal, A., AlBakheet, A., Nirmal, M. S., Jeprel, H. A., Eldali, A., Al‐Tweigeri, T., Tulbah, A. M., Ajarim, D. S., Malik, O. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063204 · Cited by 161
“Though it is a multistep process during which genetic alterations accumulate, molecular and pathological evidence suggests that DCIS is a precursor to invasive disease [15,16,17,18].”
BackgroundMechanotransduction from the ECM to the genome: Are the pieces now in place?
Gieni, R. S., & Hendzel, M. J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21364 · Cited by 147
Proinvasion Metastasis Drivers in Early-Stage Melanoma Are Oncogenes
Scott, K. L., Nogueira, C., Heffernan, T. P., van Doorn, R., Dhakal, S., Hanna, J. A., Min, C., Jaskelioff, M., Xiao, Y., Wu, C.-J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.025 · Cited by 141
“Although significant data exist in support of a classical model of stepwise accumulation of genetic events that endow increasing malignant potential, the identification of extensive genome rearrangements in early-stage cancers (driven in part by telomere crisis) (Rudolph et al., 2001; Chin et al., 2004) raises the pos…”
McManus, K. J., Barrett, I. J., Nouhi, Y., & Hieter, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813414106 · Cited by 133
Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies
Lee, J.-K., Choi, Y.-L., Kwon, M., & Park, P. J. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044446 · Cited by 135
Role of genomic instability in arsenic-induced carcinogenicity. A review
Bhattacharjee, P., Banerjee, M., & Giri, A. K. (2013) · Environment International · doi:10.1016/j.envint.2012.12.004 · Cited by 150
“, 2012), breast cancer (Chin et al., 2004),myeloidmalignancies (Sallmyr et al.”
BackgroundA Prospective Study of Relative Telomere Length and Postmenopausal Breast Cancer Risk
De Vivo, I., Prescott, J., Wong, J. Y. Y., Kraft, P., Hankinson, S. E., & Hunter, D. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0998 · Cited by 130
“This most likely occurs during the transition from usual ductal hyperplasia to carcinoma in situ (8).”
BackgroundStrunnikova, M., Schagdarsurengin, U., Kehlen, A., Garbe, J. C., Stampfer, M. R., & Dammann, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.3923-3933.2005 · Cited by 147
“In the presence of functional p53, a mostly viable growth arrest (agonescence) occurs; in the absence of functional p53, the HMEC exhibit the massive cell death associated with crisis (5, 36).”
BackgroundSelf-citationHampton, O. A., Den Hollander, P., Miller, C. A., Delgado, D. A., Li, J., Coarfa, C., Harris, R. A., Richards, S., Scherer, S. E., Muzny, D. M., et al. (2009) · Genome Research · doi:10.1101/gr.080259.108 · Cited by 129
Chromosomal Instability in Tumor Initiation and Development
Bach, D., Zhang, W., & Sood, A. K. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3235 · Cited by 140
“This role of telomeres has also been detected in cancer precursor lesions, for instance in colonic adenomas with high-grade dysplasia (54) and in ductal carcinoma in situ (55).”
Role of telomeres and telomerase in genomic instability, senescence and cancer
Deng, Y., & Chang, S. S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700673 · Cited by 153
“In human breast cancers, telomere shortening occurs early during breast tumorigenesis, and genomic instability fueled by dysfunctional telomeres is associated with the transition from benign ductal hyperplasia to malignant ductal carcinoma in situ (Figure 1c).(40,41) Telomerase is reactivated in the majority of advanc…”
BackgroundMammary stem cells and progenitors: targeting the roots of breast cancer for prevention
Tharmapalan, P., Mahendralingam, M. J., Berman, H. K., & Khokha, R. (2019) · The EMBO Journal · doi:10.15252/embj.2018100852 · Cited by 137
“…(e.g., EZH2), or aberrant activation of signaling pathways (e.g., p38; Wellings et al , 1975; Sporn, 1976; Deng et al , 1996; Lakhani et al , 1999; Porter et al , 2003; Chin et al , 2004; Ellsworth et al , 2004; Larson et al , 2005; Clarke et al , 2006; Yao et al , 2006; Tripathi et al , 2008).”
Salvador, S., Rempel, A., Soslow, R. A., Gilks, C. B., Huntsman, D. D., & Miller, D. M. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.05.010 · Cited by 128
“The acquisition of chromosomal instability as an early or even an initiating event in the oncogenesis of these lesions is similar to that described in ductal carcinoma in situ of the breast [36].”
BackgroundNovák, P., Jensen, T. J., Garbe, J. C., Stampfer, M. R., & Futscher, B. W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4977 · Cited by 126
“breast lesions, is seen in the cultured HMEC at the telomere dysfunction barrier (3, 9, 13, 17).”
Self-citationVariation at theTERTlocus and predisposition for cancer
Baird, D. M. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239941000147x · Cited by 129
Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis
Pinzaru, A. M., Hom, R. A., Beal, A., Phillips, A. F., Ni, E., Cardozo, T., Nair, N., Choi, J., Wuttke, D. S., Sfeir, A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.008 · Cited by 114
“Additional evidence in support of this paradigm emerged from the analysis of telomere dynamics in human tumors (Chin et al., 2004; Gordon et al., 2003; Rudolph et al., 2001) and the detection of telomeric fusions in several types of cancers (Lin et al., 2010; Simpson et al., 2015).”
BackgroundAPC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
Sansregret, L., Patterson, J. O., Dewhurst, S. M., López‐García, C., Koch, A., McGranahan, N., Chao, W. C. H., Barry, D. J., Rowan, A., Instrell, R., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0645 · Cited by 125
Progressive 3q Amplification Consistently Targets SOX2 in Preinvasive Squamous Lung Cancer
McCaughan, F. M., Pole, J. C. M., Bankier, A. T., Konfortov, B. A., Carroll, B., Falzon, M., Rabbitts, T. H., George, P. J., Dear, P. H., & Rabbitts, P. H. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0005oc · Cited by 109
Lesurf, R., Aure, M. R. R., Mørk, H. H., Vitelli, V., Sauer, T., Geisler, J., Hofvind, S. S. H., Borgen, E., Børresen‐Dale, A., Engebråten, O., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.051 · Cited by 134
Li, X., Wang, X., Song, W., Xu, H., Huang, R., Wang, Y., Zhao, W., Xiao, Z., & Yang, X. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0688 · Cited by 109
“driver of tumorigenesis, cancer cells also need a certain level of genome stability to ensure their viability and proliferation potential (44).”
BackgroundHeselmeyer‐Haddad, K., Berroa-Garcia, L., Bradley, A., Ortiz-Melendez, C., Lee, W.-J., Christensen, R., Prindiville, S. A., Calzone, K. A., Soballe, P. W., Hu, Y., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.07.012 · Cited by 118
The Role of Extracellular Matrix Proteins in Breast Cancer
Lepucki, A., Orlińska, K., Mielczarek‐Palacz, A., Kabut, J., Olczyk, P., & Komosińska‐Vassev, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051250 · Cited by 114
Telomere instability and cancer
Londoño‐Vallejo, A. (2007) · Biochimie · doi:10.1016/j.biochi.2007.07.009 · Cited by 104
Telomeres and telomerase in cancer stem cells
Ju, Z., & Rudolph, K. L. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.040 · Cited by 100
Letsolo, B. T., Rowson, J., & Baird, D. M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1183 · Cited by 94
“Consistent with this, telomere length is reduced in some types of carcinoma compared to matched normal tissue (9–11) and an increase in anaphase-bridging, a surrogate marker of telomere fusion, is detected at the adenoma-carcinoma transition, a point that is characterized by increased chromosomal instability in colore…”
BackgroundSerrano, D., Bleau, A., Fernandez‐Garcia, I., Fernández‐Marcelo, T., Iniesta, P., Ortíz-de-Solórzano, C., & Calvo, A. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-96 · Cited by 100
“Deconvolution, linear unmixing and image segmentation were applied following previously published protocols in order to reduce the background signal and improve quantification accuracy [42].”
MethodWRN at telomeres: implications for aging and cancer
Multani, A. S., & Chang, S. (2007) · Journal of Cell Science · doi:10.1242/jcs.03397 · Cited by 95
“The observation that premature senescence characteristic of WS cells can be rescued by ectopic expression of telomerase suggests a crucial role for telomere integrity in the pathogenesis of WS (Wyllie et al., 2000; Choi et al., 2001; Crabbe et al., 2004).”
BackgroundRaynaud, C. M., Sabatier, L., Philipot, O., Olaussen, K. A., & Soria, J. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.11.006 · Cited by 106
“Occasionally, however, one r a few cells escape this protective mechanism, leading o accumulation of multiple genomic and epigenomic aberations and thus acquisition of additional cancer hallmark eatures [46].”
BackgroundDePinho, R. A., & Polyak, K. (2004) · Nature Genetics · doi:10.1038/ng0904-932 · Cited by 91
Bull, C., & Fenech, M. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108006988 · Cited by 91
Targeted and nontargeted effects of ionizing radiation that impact genomic instability
Maxwell, C. A., Fleisch, M. C., Costes, S. V., Erickson, A. C., Boissière, A., Gupta, R., Ravani, S. A., Parvin, B., & Barcellos-Hoff, M. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1212 · Cited by 89
“Given that genomic instability is highly correlated with early events in breast cancer progression (24, 41), RIGI is likely an important determinant of radiation risk.”
p16INK4a as a Second Effector of the Telomere Damage Pathway
Jacobs, J. J. L., & de Lange, T. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2104 · Cited by 87
Aneuploidy in Cancer: Seq-ing Answers to Old Questions
Knouse, K. A., Davoli, T., Elledge, S. J., & Amon, A. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-042616-072231 · Cited by 99
Epidemiologic evidence for a role of telomere dysfunction in cancer etiology
Prescott, J., Wentzensen, I. M., Savage, S. A., & De Vivo, I. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.06.009 · Cited by 87
Telomere Dysfunction in Peripheral Lymphocytes as a Potential Predisposition Factor for Renal Cancer
Shao, L., Wood, C. G., Zhang, D., Tannir, N. M., Matin, S., Dinney, C. P., & Wu, X. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.05.112 · Cited by 85
Genome evolution in ductal carcinoma in situ: invasion of the clones
Casasent, T. D., Edgerton, M. E., & Navin, N. E. (2016) · The Journal of Pathology · doi:10.1002/path.4840 · Cited by 90
“DCIS and Intratumour Heterogeneity Intratumour heterogeneity (ITH) is frequently reported in invasive breast cancers [31,4853] and in DCIS studies profiling DNA, RNA and protein levels [17,26,37,54-61].”
BackgroundGreshock, J. D., Nathanson, K. L., Martin, A., Zhang, L., Coukos, G., Weber, B. L., & Zaks, T. Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3674 · Cited by 91
“In the future, this may be remedied by techniques that effectively evaluate zthe genome of single cells (38).”
Genetic variation in five genes important in telomere biology and risk for breast cancer
Savage, S. A., Chanock, S. J., Lissowska, J., Brinton, L. A., Richesson, D. A., Pepłońska, B., Bardin‐Mikolajczak, A., Zatoński, W. A., Szeszenia‐Dąbrowska, N., & García‐Closas, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603934 · Cited by 76
NEIL3 Repairs Telomere Damage during S Phase to Secure Chromosome Segregation at Mitosis
Zhou, J., Chan, J., Lambelé, M., Yusufzai, T., Stumpff, J., Opresko, P. L., Thali, M., & Wallace, S. S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.020 · Cited by 75
“Furthermore, telomere dysfunction has been shown to contribute to the initiation and progression of tumorigenesis as demonstrated by telomere erosion, DNA bridging, and chromosomal instability in colon, prostate, and breast cancers (Chin et al., 2004; Meeker et al., 2002; Rudolph et al., 2001).”
BackgroundProcessing of Human Reduction Mammoplasty and Mastectomy Tissues for Cell Culture
LaBarge, M. A., Garbe, J. C., & Stampfer, M. R. (2013) · Journal of Visualized Experiments · doi:10.3791/50011 · Cited by 74
Self-citationTherapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 96
“[54] Chin K, de Solorzano CO, Knowles D, Jones A, Chou W, Rodriguez EG, et al.”
BackgroundSelf-citationWhole cell segmentation in solid tissue sections
Baggett, D., Nakaya, M., McAuliffe, M., Yamaguchi, T. P., & Lockett, S. (2005) · Cytometry Part A · doi:10.1002/cyto.a.20162 · Cited by 71
Self-citationTelomere Length Dynamics and the Evolution of Cancer Genome Architecture
Cleal, K., Norris, K., & Baird, D. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020482 · Cited by 81
“The promotion of large scale genome rearrangements and instability by telomere dysfunction 317 has been well documented [51, 114-118].”
BackgroundMultiple Mechanisms of Telomere Maintenance Exist in Liposarcomas
Johnson, J. E., Varkonyi, R. J., Schwalm, J., Cragle, R., Klein–Szanto, A. J., Patchefsky, A. S., Cukierman, E., von Mehren, M., & Broccoli, D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0684 · Cited by 81
Metadata
- Authors
- Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., Miranda, M., Krig, S., Garbe, J., Stampfer, M., Yaswen, P., Gray, J. W., & Lockett, S. J.
- Affiliations
- University of California, San Francisco (US)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Gray, Joe W
- Venue
- Nature Genetics
- Published
- 2004-08-08
- Volume
- 36
- Issue
- 9
- Pages
- 984-988
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2053300345
- Semantic Scholar
- 005930a6472117d3d08d09415087ec01d5c8ecb1
- Cited by
- 361
- References
- 30
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 10 · 2020: 8 · 2019: 8 · 2018: 17 · 2017: 15 · 2016: 19 · 2015: 19 · 2014: 14 · 2013: 24 · 2012: 24
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy
- U.S. Department of Health and Human Services
- Avon Foundation for Women
- Universiteit Leiden
- National Institutes of Health
- National Cancer Institute (R01CA101359, R01CA090421)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- genomic instability, telomere crisis, breast cancer progression, ductal carcinoma in situ, usual ductal hyperplasia, mammary epithelial cells, ZNF217, cell immortalization, fluorescence in situ hybridization
- MeSH terms
- Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Humans, Hyperplasia, Tumor Cells, Cultured, Ultrasonography, Telomere, In Situ Hybridization, Carcinoma, Ductal, Breast, Disease Progression, Chromosomal Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.